COVID-19

Neutralizing antibodies increased by 34- to 27-fold compared to pre-booster levels when administered at 8 or 11 months post-primary series.

The TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR multiplex assay can differentiate between 3 different viral infections (including COVID-19), making it highly cost-effective.

Novavax’s quadrivalent influenza vaccine candidate has previously induced cross-reactive polyfunctional CD4+ T-cell responses, according to a company press release.

Research showed the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (Pfizer-BioNTech) increases neutralizing antibody response against multiple variants of Omicron.

Researchers suggest that all patients with HIV should be considered for additional vaccine doses, among other measures, to reduce their risk.

The vaccine is in a ready-to-use liquid formulation in a vial containing 10 doses, with the vaccination regimen calling for a pair of 0.5 ml doses administered intramuscularly 21 days apart.

Many people wanted life to feel normal during the COVID-19 pandemic; however, this reason, among many, resulted in people not adhering to public health measures in the United States.

The COVID-19 vaccine may generally increase oxygenation ability, which could lead to lower mortality in patients who are treated using invasive mechanical ventilation.

Because we need to be prepared and respond to future crises, making these changes permanent is a top priority for the profession of pharmacy.

Latest Information is key to helping patients stay healthy amid continuously changing landscape.

At month 6 post-COVID-19 infection, 123 patients received a diagnosis of type 1 diabetes (T1D) and only 72 were diagnosed with T1D at 6 months post-non-COVID-19 respiratory infection.

The availability of bivalent mRNA COVID-19 boosters, which provide broader protection, will likely increase vaccine demand in the fall

The Moderna bivalent vaccine is authorized for children 6 years of age and older, and the Pfizer-BioNTech vaccine is authorized for children 5 years of age and older.

Investigators find that individuals with both conditions are more likely to develop severe disease than those in the control group.

Vaccines reduce the risk of COVID-19 infection and hospitalization, but a recent study suggests that misinformation could make adults hesitant to vaccinate children 5 to 11 years of age.

Loosened restrictions will likely create a more pronounced influenza season this fall.

Respiratory infections have been associated with onset of type 1 diabetes in previous research, but this risk was notably higher among those with COVID-19 in this study.

FDA revises emergency use authorization to grant prescribing authority for Pfizer’s Paxlovid antiviral treatment for COVID-19.

The value of a patient-first approach and telehealth for addressing the complex health coordination needs of those with these pulmonary conditions has never been more critical.

Patients could have a better immune response against the omicron variant of COVID-19 with a second booster of the bivalent mRNA-1273.214 vaccine at a 50 μg dose.

Take steps to safeguard prescribing, dispensing, and patient use of the COVID-19 antiviral medication.

Pfizer and BioNTech have also initiated a phase 1/2/3 study evaluating the safety, tolerability, and immunogenicity of different doses and dosing regimens with the vaccine in children.

The data showed moral concerns about fairness, loyalty, and purity influenced county-level vaccination rates, but care and authority did not.

Analyses of more than 30,000 adults in the United Kingdom from 9 prospective cohort studies finds a high pre-pandemic BMI was associated with the infection.

In a recent study, researchers observed that more than one-third of children with a primary immunodeficiency disease died from COVID-19.